Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients

NCT00128778 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

288

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Pegylated liposomal doxorubicin

Sponsor

Spanish Breast Cancer Research Group

Collaborators

[object Object]